MicroRNAs as Targets for Cancer Diagnosis: Interests and Limitations

Behrouz Shademan ¹ , Vahidreza Karamad ¹ , Alireza Nourazarian ², Sepideh Masjedi ³, Alireza Isazadeh ⁴, Fatma Sogutlu ¹, Cigir Biray Avcı ¹ *

Cited by CrossRef: 0

1- Zhao C, Tang Q, Yang C, Zhou L, Peng J, Zhang T, Zhou S, Li Y. Stereotactic body radiation therapy suppresses myeloid-derived suppressor cells by regulating miR-21/Sorbin and SH3 Domain-containing Protein 1 axis. Hum Exp Toxicol. 2024;43 [Crossref]

2- Chen H. microRNA-Based Cancer Diagnosis and Therapy. IJMS. 2023;25(1):230 [Crossref]

3- Kronstein-Wiedemann R, Künzel S, Thiel J, Tonn T. Role of MiRNA in the Regulation of Blood Group Expression. Transfus Med Hemother. 2024;:1 [Crossref]

4- Abolhasanzadeh N, Sarabandi S, Dehghan B, Karamad V, Avci C, Shademan B, Nourazarian A. Exploring the intricate relationship between miRNA dysregulation and breast cancer development: insights into the impact of environmental chemicals. Front Immunol. 2024;15 [Crossref]